193
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

A comprehensive review on QbD driven analytical procedures developed for the analysis of various drugs

ORCID Icon, ORCID Icon & ORCID Icon

References

  • Das, V.; Bhairav, B.; Saudagar, R. B. Quality by Design Approaches to Analytical Method Development. Res. J. Pharm. Technol. 2017, 10, 3188. DOI: 10.5958/0974-360X.2017.00567.4.
  • ICH Secretariat. Overview of ICH. https://admin.ich.org/sites/default/files/inline-files/ICH_leaflet_2022_0318.pdf. (accessed Nov 28, 2019)
  • International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q8 (R2): Harmonized tripartite guideline, Pharmaceutical Development: Geneva, 2009. https://database.ich.org/sites/default/files/Q8%28R2%29%20Guideline.pdf
  • International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q9:(R1), Harmonized tripartite guideline, Quality Risk Management;: Geneva, 2023. https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Guideline_Step4_2023_0126_0.pdf
  • International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Harmonized tripartite guideline, Pharmaceutical Quality System: Geneva, 2008. https://database.ich.org/sites/default/files/Q10%20Guideline.pdf
  • International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q11: Harmonized tripartite guideline, Development and Manufacture of Drug substances (chemical entities and biotechnological/biological entities), Geneva, 2012. https://database.ich.org/sites/default/files/Q11%20Guideline.pdf
  • International Council for Harmonisation of Technical Requirements for Pharmaceuticals For Human Use, Q14 : Harmonized tripartite guideline, An Analytical Procedure Development, Draft Version: Geneva, 2022. https://database.ich.org/sites/default/files/ICH_Q14_Document_Step2_Guideline_2022_0324.pdf
  • Bezerra, Marcos Almeida; Santelli, Ricardo Erthal; Oliveira, Eliane Padua; Villar, Leonardo Silveira; Escaleira, Luciane Amelia. Response Surface Methodology (RSM) as a Tool for Optimization in Analytical Chemistry. Talanta. 2008, 76, 965–977. DOI: 10.1016/j.talanta.2008.05.019.
  • Jadhav, M. L.; Tambe, S. R.; Girase, M. V. Analytical Quality by Design Approach for Development of UV Spectrophotometric Methods in the Estimation of Trospium Chloride from Capsule Dosage Form. Int. J. Pharm. Pharm. 2014, 6, 530–533.
  • Beg, S.; Kohli, K.; Swain, S.; Hasnain, M. S. Development and Validation of RP-HPLC Method for Quantitation of Amoxicillin Trihydrate in Bulk and Pharmaceutical Formulations Using Box-Behnken Experimental Design. J. Liq. Chromatogr. Relat. 2012, 35, 393–406. DOI: 10.1080/10826076.2011.601493.
  • Amruta, S.; Khurd, P. B.; Miniyar Sandip, R.; More Kajal, V.; Doshi, V.; Gawande, A. S.; Sutar, A. M.; Kashid Shraddha, V.; Tathe, S. S.; Gaikwad .; et al. Analytical Method Development and Validation of Vildagliptin by Using Quality by Design Approach. Eur. J. Biomed. Pharm. 2020, 7, 223–229.
  • Nayak, R.; Thangaraj Narenderan, S.; Nainar Meyyanathan, S.; Babu, B. Analytical Quality by Design-Based LC-MS/MS Method for the Determination of Riociguat in Its Formulations. J. Appl. Pharm. Sci. 2021, 11, 100–106. DOI: 10.7324/JAPS.2021.1101208.
  • Raman, N. V. V. S. S.; Reddy Mallu, U.; Bapatu, H. R. Analytical Quality by Design Approach to Test Method Development and Validation in Drug Substance Manufacturing. J. Chem. 2015, 2015, 1–8. DOI: 10.1155/2015/435129.
  • Schweitzer, M.; Pohl, M.; Hanna-Brown, M.; Nethercote, P.; Borman, P.; Hansen, G.; Smith, K.; Larew, J. Implications and Opportunities of Applying QbD Principles to Analytical Measurements. Pharm. Tech. 2010, 34, 1–12.
  • United States Pharmacopeia, Chapter <1220> Analytical Procedure Life Cycle (1220). USP-NF 2022, Issue 1, 2022. https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/usp-nf-notices/gc-1220-pre-post-20210924.pdf
  • Panda, S. S.; Rath, J.; Ravi Kumar Bera, V. V. QbD Driven Development and Validation of UV Spectrophotometric Method for Estimation of Paliperidone in Extended-Release Tablet Dosage Form. Tacl. 2018, 8, 510–518. DOI: 10.1080/22297928.2018.1446845.
  • Jain, A.; Sharma, T.; Sharma, G.; Khurana, R. K.; Katare, O. P.; Singh, B. QbD-Driven Analytical Method Development and Validation for Raloxifene Hydrochloride in Pure Drug and Solid Oral Dosage Form. Anal. Chem. Lett. 2019, 9, 463–477. DOI: 10.1080/22297928.2019.1624193.
  • Bandopadhyay, S.; Beg, S.; Katare, O. P.; Sharma, T.; Singh, B. Integrated Analytical Quality by Design (AQbD) Approach for the Development and Validation of Bioanalytical Liquid Chromatography Method for Estimation of Valsartan. J. Chromatogr. Sci. 2020, 58, 606–621. DOI: 10.1093/chromsci/bmaa024.
  • Jena, B. R.; Koteswara Rao, G. S. N.; Alavala, R. R.; Desu, P. K.; Chakravarthi, G.; Swain, S.; Pradhan c, D. P.; Niharika, P. Response Surface Methodology Driven Systematic Development of a Stability- Indicating RP-UPLC Method for the Quantification of Aliskiren: A Renin Inhibitor. JPRI. 2021, 33, 195–211. DOI: 10.9734/jpri/2021/v33i52B33617.
  • Panda, S. S.; Bera, V. V. R. K.; Beg, S.; Sahu, S. K. Ultrafast Liquid Chromatographic Method Development and Its Validation for Quantification of Telaprevir in Pharmaceutical Dosage Form by Using Quality by Design Approach. J. Chromatogr. Sci. 2015, 53, 1193–1202. DOI: 10.1093/chromsci/bmu228.
  • Khurana, R. K.; Rao, S.; Beg, S.; Katare, O. P.; Singh, B. Systematic Development and Validation of a Thin-Layer Densitometric Bioanalytical Method for Estimation of Mangiferin Employing Analytical Quality by Design (AQbD) Approach. J. Chromatogr. Sci. 2016, 54, 829–841. DOI: 10.1093/chromsci/bmw001.
  • Saquib Hasnain, M.; Siddiqui, S.; Rao, S.; Mohanty, P.; Jahan Ara, T.; Beg, S. QbD Driven Development and Validation of a Bioanalytical LC-MS Method for Quantification of Fluoxetine in Human Plasma. J Chromatogr. Sci. 2016, 54, 1–8. DOI: 10.1093/chromsci/bmv248.
  • Burnett, K. L.; Harrington, B.; Grau, T. W. QbD in Liquid Chromatographic Applications; Fanalis, S. Haddad, P. A. Poole, C. F., Eds.; Elsevier: New York, 2013.
  • Mahapatra, A.; Meyyanathan, S. N. Approach of Analytical Quality by Design and Regulatory Need. IJHS. 2022, 6, 2572–2592. DOI: 10.53730/ijhs.v6nS5.9208.
  • Ullman, A. H.; Thorpe, T. M.; Boutilier, G. D. Analytical Problem Solving: Selection of Analytical Methods. In Encyclopaedia of Analytical Chemisry; Robert A. Meyers, Ed.; John Wiley & Sons, Ltd: New York, 2006; 1–9.
  • Vijay Kumar, K. Quality by Design Approach for Analytical Method Development. EPRA Int. J. Res. Dev. 2021, 6, 54–60. DOI: 10.36713/epra2016.
  • Alhakeem, M. A.; Ghica, M. V.; Pîrvu, C. D.; Anuța, V.; Popa, L. Analytical Quality by Design with the Lifecycle Approach: A Modern Epitome for Analytical Method Development. Acta Med. Marisiensis. 2019, 65, 37–44. DOI: 10.2478/amma-2019-0010.
  • Bettencourt, D. S.; Bulska, E.; Godlewska Zylkiewicz, B. Analytical Measurement: measurement Uncertainty and Statistics; European Commission-Joint Research Centre, Publications Office of the European Union: Luxembourg, 2013; pp 19–85. DOI: 10.2787/58527.
  • USP Validation and Verification Expert Panel. Analytical Target Profile: Structure and Application throughout the Analytical Lifecycle. Pharmacop. Forum. 2016, 42, 5.
  • Davis, B.; Lundsberg, L.; Cook, G. PQLI Control Strategy Model and Concepts. J. Pharm. Innov. 2008, 3, 95–104. DOI: 10.1007/s12247-008-9035-1..
  • Piriou, J.; Elissondo, B.; Hertschuh, M.; Ollivier, R. Control Strategy as the Keystone of the Product Life Cycle, from Product/Process Understanding to Continuous Process Verification and Improvement. Pharm. Eng 2012, 32, 1–8.
  • David, V.; Miroslav, K. Selected Overview of Risk Assessment Techniques. Problemy Eksploatacji. 2009, 4, 19–32.
  • Jadhav, M. L.; Tambe, S. R. Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Propafenone Hydrochloride in Tablet Dosage Form. Chrom. Res. Int. 2013, 2013, 1–9. DOI: 10.1155/2013/676501.
  • Prajapati, P.; Patel, A.; Shah, S. Application of DoE-Based Analytical QRM to Development of the Multipurpose RP-HPLC Method for Estimation of Multiple FDC Products of Telmisartan Using Enhanced AQbD Approach. J. Chromatogr. Sci. 2022, 60, 525–537. DOI: 10.1093/chromsci/bmab070.
  • Prajapati, P.; Radadiya, V.; Shah, S. Failure Mode Critical Effect Analysis and Design of Experiment-Based Robust Chromatographic Method for Simultaneous Estimation Lornoxicam and Eperisone Hydrochloride. J. Chromatogr. Sci. 2020, 58, 929–939. DOI: 10.1093/chromsci/bmaa064.
  • Prajapati, P.; Patel, H. B.; Shah, S. DoE Based Failure Mode Effect Analysis (FMEA) to Development of Stability Indicating HPTLC Method for Estimation of Apremilast. SN Appl. Sci. 2020, 2, 1371. DOI: 10.1007/s42452-020-2890-1.
  • Ramalingam, P.; Bhadraya, K.; Padmanabha Reddy, Y. Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics. Int. J. Anal. Chem. 2015, 2015, 1–9. DOI: 10.1155/2015/868727.
  • Priyanka, P. P.; Sadikali, F. S.; Machindra, J. C.; Sanjay, R. C. Quality by Design in Analytical Method Development and Validation. J. Environ. Sci. 2017, 2, 39–45.
  • K. Adiki, S.; M, P.; Dey, B.; Katakam, P.; H. Assaleh, F.; T. Hwisa, N.; K. Singla, R.; R. Chandu, B. Design of Experiment Assisted UV-Visible Spectrophotometric and RP-HPLC Method Development for Ambrisentan Estimation in Bulk and Formulations. WJAC. 2014, 2, 23–30. DOI: 10.12691/wjac-2-2-2.
  • Fanse, S.; Baghel, M.; Bhamre, P.; Rajput, S. A Novel QbD Based SPE-HPLC Bio-Analytical Method for Edaravone in Rat Plasma. A Pharmacokinetic Study. IJPER. 2016, 50, 563–573. DOI: 10.5530/ijper.50.4.8.
  • Beg, S.; Chaudhary, V.; Sharma, G.; Garg, B.; Panda, S. S.; Singh, B. QbD Oriented Development and Validation of a Bioanalytical Method for Nevirapine with Enhanced Liquid-Liquid Extraction and Chromatographic Separation. Biomed. Chromatogr. 2016, 30, 818–828. DOI: 10.1002/bmc.3613.
  • Smajic, M.; Vujic, Z.; Mulavdic, N.; Brboric, J. An Improved HPLC Method for Simultaneous Analysis of Losartan Potassium and Hydrochlorothiazide with the Aid of a Chemometric Protocol. Chromatographia. 2013, 76, 419–425. DOI: 10.1007/s10337-013-2388-8.
  • Palakurthi, A. K.; Dongala, T.; Katakam, L. N. R. QbD Based Development of HPLC Method for Simultaneous Quantification of Telmisartan and Hydrochlorothiazide Impurities in Tablets Dosage Form. Pract. Lab. Med. 2020, 21, e00169. DOI: 10.1016/j.plabm.2020.e00169.
  • Wani, Y. B.; Patil A. D. D. An Experimental Design Approach for Optimization of Spectrophotometric Method for Estimation of Cefixime Trihydrate Using Ninhydrin as Derivatizing Reagent in Bulk and Pharmaceutical Formulation. J. Saudi Chem. Soc. 2017, 21, S101–S111. DOI: 10.1016/j.jscs.2013.11.001.
  • Yu, L. X.; Amidon, G.; Khan, M. A.; Hoag, S. W.; Polli, J.; Raju, G. K.; Woodcock, J. Understanding Pharmaceutical Quality by Design. AAPS J. 2014, 16, 771–783. DOI: 10.1208/s12248-014-9598-3.
  • Zhang, L.; Mao, S. Application of Quality by Design in the Current Drug Development. Asian J. Pharm. Sci. 2017, 12, 1–8. DOI: 10.1016/j.ajps.2016.07.006.
  • Nadella, P. N.; Nadh Ratnakaram, V.; Navuluri, S. QbD-Based UPLC Method for Quantification of Brexpiprazole in Presence of Impurities and Application to In Vitro Dissolution. J. Chromatogr. Sci 2021, 59, 223–240. DOI: 10.1093/chromsci/bmaa099.
  • Bhatt, P.; Saquib Hasnain, M.; Nayak, A. K.; Hassan, B.; Beg, S. Development and Validation of QbD-Driven Bioanalytical LC-MS/MS Method for the Quantification of Paracetamol and Diclofenac in Human Plasma. Anal. Chem. Lett. 2018, 8, 677–691. DOI: 10.1080/22297928.2018.1429305.
  • Nunnally, B. K.; McConnell, J. S. Six Sigma in the Pharmaceutical Industry: Understanding, Reducing, and Controlling Variation in Pharmaceuticals and Biologics. CRC Press: New York, 2007.
  • Bapatu, H. R.; Maram, R. K.; Cho, W. H.; Pasagadugula, V. B. R. QbD Approach Method Development for Estimation of Dabigatran Etexilate along with Its Impurities and Identification of Degradants in Capsule Dosage Form. AJAC. 2016, 07, 494–524. DOI: 10.4236/ajac.2016.76047.
  • Patel, K. Y.; Dedania, Z. R.; Dedania, R. R.; Patel, U. QbD Approach to HPLC Method Development and Validation of Ceftriaxone Sodium. Futur. J. Pharm. Sci. 2021, 7, 1–10. DOI: 10.1186/s43094-021-00286-4.
  • Sangshetti, J. N.; Deshpande, M.; Zaheer, Z.; Shinde, D. B.; Arote, R. Quality by Design Approach: Regulatory Need. Arab J. Chem. 2017, 10, S3412–S3425. DOI: 10.1016/j.arabjc.2014.01.025.
  • Mogal, V.; Dusane, J.; Borase, P.; Thakare, P.; Kshirsagar, S. A Review on Quality by Design. Pharm. Biol. Eval 2016, 3, 313–319.
  • Orlandini, S.; Pinzauti, S.; Furlanetto, S. Application of Quality by Design to the Development of Analytical Separation Methods. Anal. Bioanal. Chem. 2013, 405, 443–450. DOI: 10.1007/s00216-012-6302-2.
  • Phadke, R.; Gosar, A.; Mali, R.; Patil, D. A Review on Quality by Design Approaches to Analytical Method Development. Indo Am. J. Pharm. Sci. 2019, 9, 3044–3055.
  • Singh, B.; Kumari, N.; Saini, G.; Chaudhary, A.; Verma, K.; Vyas, M. Quality by Design: A Systematic Approach for the Analytical Method Validation. J. Drug Deliv. Ther. 2019, 9, 1006–1012. DOI: 10.22270/jddt.v9i3-s.3114.
  • Saminathan, J. Quality by Design (AQbD) in Pharmaceutical Development. Spinco Biotech Cutting Edge. 2017, 7, 38–45.
  • Katekar, V.; Sangule, D.; Bhurbhure, O.; Ingle, P.; Dhage, S.; Jadhav, K. A Review on Quality by Design Approach in Analytical Methods. J. Drug Deliv. Ther. 2022, 12, 255–261. DOI: 10.22270/jddt.v12i3-S.5386.
  • Thakor, N. S.; Amrutkar, S. V. Implementing Quality by Design (QbD) in Chromatography. Austin J. Anal. Pharm. Chem. 2017, 4, 1–5.
  • Kumar, N.; Sangeetha, D. Analytical Method Development by Using QbD – An Emerging Approach for Robust Analytical Method Development. J. Pharm. Sci. Res. 2020, 12, 1298–1305.
  • Fukuda, I. M.; Pinto, C. F. F.; Moreira, C. D S.; Saviano, A. M.; Lourenço, F. R. Design of Experiments (DoE) Applied to Pharmaceutical and Analytical Quality by Design (QbD). Braz. J. Pharm. Sci. 2018, 54, 1–16. DOI: 10.1590/s2175-97902018000001006.
  • Jaiprakash, N.; Sangshetti, M.; Deshpande, Z.; Zaheer, D. B.; Shinde, R.; Arote . Quality by Design Approach: Regulatory Need. Arab. J. Chem. 2014, 10, 1–14. DOI: 10.1016/j.arabjc.2014.01.025.
  • Ferreira, S. L. C.; Bruns, R. E.; Ferreira, H. S.; Matos, G. D.; David, J. M.; Brandao, G. C.; da Silva, E. G. P.; Portugal, L. A.; dos Reis, P. S.; Souza, A. S.; dos Santos, W. N. L. Box-Behnken Design: An Alternative for the Optimization of Analytical Methods. Anal. Chim. Acta. 2007, 597, 179–186. DOI: 10.1016/j.aca.2007.07.011.
  • Ferreira, S. L. C.; Dos Santos, W. N. L.; Quintella, C. M.; Neto, B. B.; Bosque-Sendra, J. M. Doehlert Matrix: A Chemometric Tool for Analytical Chemistry—Review. Talanta. 2004, 63, 1061–1067. DOI: 10.1016/j.talanta.2004.01.015.
  • Ferreira, S. L. C.; Bruns, R. E.; Galvao Paranhos da Silva, E.; Lopes dos Santos, W. N.; Quintella, C. M.; David, J. M.; Bittencourt de Andrade, J.; Breitkreitz, M. C.; Jardim, I. C. S. F.; Neto, B. B. Statistical Designs and Response Surface Techniques for the Optimization of Chromatographic Systems. J. Chromatogr. A. 2007, 1158, 2–14. DOI: 10.1016/j.chroma.2007.03.051.
  • Ebrahimi, H.; Najafabadi Leardi, R.; Jalali-Heravi, M. Experimental Design in Analytical Chemistry- Part I: Theory. J. AOAC Int. 2014, 97, 3–11. DOI: 10.5740/jaoacint.sgeebrahimi1.
  • Candioti, L. V.; De Zan, M. M.; Cámara, M. S.; Goicoechea, H. C. Experimental Design and Multiple Response Optimization Using the Desirability Function in Analytical Methods Development. Talanta. 2014, 124, 123–138. DOI: 10.1016/j.talanta.2014.01.034.
  • Jackson, P.; Borman, P.; Campa, C.; Chatfield, M.; Godfrey, M.; Hamilton, P.; Hoyer, W.; Norelli, F.; Orr, R.; Schofield, T. Using the Analytical Target Profile to Drive the Analytical Method Lifecycle. Anal. Chem. 2019, 91, 2577–2585. DOI: 10.1021/acs.analchem.8b04596.
  • Orlandini, S.; Gotti, R.; Furlanetto, S. Multivariate Optimization of Capillary Electrophoresis Methods: A Critical Review. J. Pharm. Biomed. Anal. 2014, 87, 290–307. DOI: 10.1016/j.jpba.2013.04.014.
  • Darkunde, S. L. A Review on Quality by Design. Int. J. Pharm. Chem. Anal. 2018, 5, 1–6. DOI: 10.18231/2394-2797.2018.0001.
  • Goswami, S.; Chakraverty, R. A Review on Application of Quality by Design Concept to Analytical Techniques. Int. J. Cur. Res. Health Biol. Sci. 2016, 3, 100–108.
  • Ayre, A.; Mane, P.; Ghude, K.; Nemade, M.; Gide, P. Implementing Quality by Design- A Methodical Approach in the RP-HPLC Method Development Process. Int. J. Adv. Pharm. Res. 2014, 4, 01–06.
  • Sachin, B.; Gholve, R. R.; Ajgunde Omprakash, G.; Bhusnure, S. S.; Thonte . Analytical Method Development and Validation by QbD Approach - A Review. Der Pharm. Sin. 2015, 6, 18–24.
  • Ganorkar, S. B.; Shirkhedkar, A. A. Design of Experiments in Liquid Chromatography (HPLC) Analysis of Pharmaceuticals: Analytics, Applications, Implications and Future Prospects. Rev. Anal. Chem. 2017, 36, 1–43. DOI: 10.1515/revac-2016-0025.
  • Murugan, R. The Importance of Design Space to Analytical Methods. Spinco Biotech Cutting Edge. 2014, 4, 7–11.
  • Cerqueira, U. M. F. M.; Bezerra, M. A.; Ferreira, S. L. C.; de, R.; Araújo, J.; da Silva, B. N.; Galvao Novaes, C. Doehlert Design in the Optimization of Procedures Aiming Food analysis -A Review. Food Chem. 2021, 364, 130429.
  • Altria, K. D.; Clark, B. J.; Filbey, S. D.; Kelly, M. A.; Rudd, D. R. Application of Chemometric Experimental Designs in Capillary Electrophoresis: A Review. Electrophoresis. 1995, 16, 2143–2148. DOI: 10.1002/elps.11501601346.
  • Bajaj, M.; Nanda, S. Analytical Quality by Design (AQbD): New Paradigm for Analytical Method Development. Int. J. Dev. Res. 2015, 5, 3589–3599.
  • Janagap, P. A. S. Doehlert Uniform Shell Designs and Chromatography. J. Chromatogr. B. 2012, 910, 14– 21. DOI: 10.1016/j.jchromb.2012.05.019.
  • Bianchi, F.; Careri, M. Experimental Design Techniques for Optimization of Analytical Methods. Part I: Separation and Sample Preparation Techniques. CAC. 2008, 4, 55–74. DOI: 10.2174/157341108783339070.
  • Veuthey, J.-L.; Rudaz, S. Statistical and Chemometric Tools Applied to Pharmaceutical Analysis. Chimia. 2005, 59, 326–330. DOI: 10.2533/000942905777676461.
  • Gétaz, D.; Stroehlein, G.; Butté, A.; Morbidelli, M. Model-Based Design of Peptide Chromatographic Purification Processes. J. Chromatogr. A. 2013, 1284, 69–79. DOI: 10.1016/j.chroma.2013.01.118.
  • Dejaegher, B.; Vander Heyden, Y. The Use of Experimental Design in Separation Science. Acta Chromatogr. 2009, 2, 161–201. DOI: 10.1556/AChrom.21.2009.2.1.
  • Dejaegher, B.; Vander Heyden, Y. Experimental Designs and Their Recent Advances in Set-up, Data Interpretation, and Analytical Applications. J. Pharm. Biomed. Anal. 2011, 56, 141–158. DOI: 10.1016/j.jpba.2011.04.023.
  • Ronald Suich, G. D. Simultaneous Optimization of Several Response Variables. J. Qual. Technol. 1980, 12, 214–219. DOI: 10.1080/00224065.1980.11980968.
  • Murray, P. M.; Forfar, L. C.. The Application of Advanced Design of Experiments for the Efficient Development of Chemical Processes. Chem. Inform. 2017, 3, 1–15. DOI: 10.21767/2470-6973.100023.
  • Costa Ferreira, S. L.; Andrade Korn, M. D. G.; Ferreira, H. S.; Paranhos da Silva, E. G.; Oliveira Arau Jo, R. G.; Souza, A. S.; Macedo, S. M.; Lima, D. D. C.; de Jesus, R. M. Application of Multivariate Techniques in Optimization of Spectro-Analytical Methods. Appl. Spectrosc. Rev. Taylor & Francis: London, 2007, 42, 475–491. DOI: 10.1080/05704920701551506.
  • Hanrahan, G.; Montes, R.; Gomez, F. A. Chemometric Experimental Design-Based Optimization Techniques in Capillary Electrophoresis: A Critical Review of Modern Applications. Anal. Bioanal. Chem. 2008, 390, 169–179. DOI: 10.1007/s00216-007-1619-y.
  • Bhutani, H.; Kurmi, M.; Singh, S.; Beg, S.; Singh, B. Quality by Design (QbD) in Analytical Sciences: An Overview. Pharma Times. 2014, 46, 71–75.
  • Hibbert, D. B. Experimental Design in Chromatography: A Tutorial Review. J. Chromatogr. B. 2012, 910, 2–13. DOI: 10.1016/j.jchromb.2012.01.020.
  • Kumar, N.; Bansal, A.; Sarma, G. S.; Rawal, R. K. Chemometrics Tools Used in Analytical Chemistry: An Overview. Talanta. 2014, 123, 186–199. DOI: 10.1016/j.talanta.2014.02.003.
  • Bezerra, M. A.; Ferreira, S. L. C.; Novaes, C. G.; dos Santos, A. M. P.; Valasques, G. S.; da Mata Cerqueira, U. M. F.; dos Santos Alves, J. P. Simultaneous Optimization of Multiple Responses and Its Application in Analytical Chemistry - A Review. Talanta. 2019, 194, 941–959. DOI: 10.1016/j.talanta.2018.10.088.
  • Novaes, C. G.; Bezerra, M. A.; da Silva, E. G. P.; Pinto dos Santos, A. M.; Lago da Silva Romao, I.; Neto, J. H. S. A Review of Multivariate Designs Applied to the Optimization of Methods Based on Inductively Coupled Plasma Optical Emission Spectrometry (ICP OES). Microchem. J. 2016, 128, 31–46. DOI: 10.1016/j.microc.2016.05.015.
  • Schlabach, T. D.; Excoffier, J. L. Multi-Variate Ranking Function for Optimizing Separations. J. Chromatogr. 1988, 439, 173–184. DOI: 10.1016/S0021-9673(01)83832-2.
  • Sentellas, S.; Saurina, J. Chemometrics in Capillary Electrophoresis. Part A: Methods for Optimization. J. Sep. Sci. 2003, 26, 875–885. DOI: 10.1002/jssc.200301514.
  • Siouffi, A. M.; Phan-Tan-Luu, R. Optimization Methods in Chromatography and Capillary Electrophoresis. J. Chromatogr. A. 2000, 892, 75–106. DOI: 10.1016/s0021-9673(00)00247-8.
  • Tarley, C. R. T.; Silveira, G.; Lopes dos Santos, W. N.; Matos, G. D.; Galvao Paranhos da Silva, E.; Bezerra, M. A.; Miro, M.; Ferreira, S. L. C. Chemometric Tools in Electroanalytical Chemistry: Methods for Optimization Based on Factorial Design and Response Surface Methodology. Microchem. J. 2009, 92, 58–67. DOI: 10.1016/j.microc.2009.02.002.
  • Wold, S.; Esbensen, K.; Geladi, P. Principal Component Analysis. Chemom. Intell. Lab. Syst. 1987, 2, 37–52. DOI: 10.1016/0169-7439(87)80084-9.
  • Campaña, A.; Rodríguez, L.; González, A.; Barrero, F.; Ceba, M. Sequential Response Surface Methodology for Multi-Optimization in Analytical Chemistry with Three-Variable Doehlert Designs. Ana. Chim. Acta. 1997, 348, 237–246. DOI: 10.1016/S0003-2670(97)00155-4.
  • Varaha Bera, R. K V.; Gain, A.; Panda, S. S.; Beg, S. Spectrophotometric Determination of Sertaconazole Nitrate in Pharmaceutical Dosage Form Using Quality by Design (QbD) Framework. J. Bioanal. Biomed. 2015, 09, 235–239. DOI: 10.4172/1948-593X.1000185.
  • Prajapati, R. B.; Patel, P. B.; Mahida, R. Spectrophotometric Determination of Chlorpheniramine Maleate in Its Pharmaceutical Dosage Form Using Quality by Design Approach. J. Pharm. Sci. Biosci. Res. 2019, 9, 260–267.
  • Patel, P.; Maheda, R.; Prajapati, R. Spectrophotometric Determination of Dapoxetine in Its Pharmaceutical Dosage Form Using Quality by Design Approach. J. Pharm. Sci. Biosci. Res. 2019, 9, 253–259.
  • Parmar, S.; Patel, B.; Patel, A. Analytical Quality by Design Approach for Development and Validation of UV-Spectrophotometric Method for Estimation of Canagliflozin in Bulk and Formulation. Int. J. Pharm. Res. Sci. 2021, 12, 6498–6509. DOI: 10.13040/IJPSR.0975-8232.12(12).6598-09.
  • Kumar, M.; Kumar Shukla, A.; Singh Bishnoi, R.; Jain, C. P. Development of UV Spectrophotometric Method for the Determination of Benidipine Hydrochloride by Using Quaity by Design (QbD) Approach. Int. J. App. Pharm. 2018, 10, 92–97. DOI: 10.22159/ijap.2018v10i4.26623.
  • Kaur, N.; Singh, I.; Sharma, A.; Kumar Katual, M.; Kaur, C.; Kumar, R. Application of QbD Approach to Development and Validation of a Novel UV Spectrophotometric Method for Quantitative Estimation of Quetiapine Fumarate in Bulk and Pharmaceutical Formulation (Tablets). Saudi J. Med. Pharm. Sci 2018, 4, 249–256. DOI: 10.21276/sjmps.2018.4.2.12.
  • Anita, A.; Raj, B. Spectroscopic Analysis of Netilimicin by Derivatization Using Quality by Design for Bulk Dosage Forms. J. Glob. Trends Pharm. Sci. 2020, 11, 8705–8712.
  • Santosh, A.; Waghmare Pranit, B.; Kale, R. S.; Desai, S.; Takale, M.; Jadhav, J. P.; Bayas . Analytical Method Development and Validation for Determination of Telmisartan in Bulk and Pharmaceutical Formulation by QbD Approach. Int. J. Anal. Exp. Modal Anal. 2020, 12, 1567–1571.
  • Patel, M. N.; Kothari, C. S. Multivariate Approaches for Simultaneous Determination of Avanafil and Dapoxetine by UV Chemometrics and HPLC-QbD in Binary Mixtures and Pharmaceutical Product. J. AOAC Int. 2016, 99, 649–663. DOI: 10.2174/1573411014666180501122512.
  • Mastanamma, SK; Saidulu P..; Prathibha L.. Analytical Quality by Design Approach for Development of UV-Spectrophotometric Method in the Estimation of Lamivudine from Tablet Dosage Form. Int. J. Pharm. Tech. Res. 2016, 9, 399–406.
  • Omprakash, G.; Bhusnure Gholve, S. B.; Bawage Manoj, V.; Todkar Padmaja S.; Giram . Analytical Method Development and Validation of Prednisolone Sodium Phosphate by QbD Approach. J. Pharm. Biol. Sci. 2015, 10, 64–75. DOI: 10.9790/3008-10636475.
  • Bhusnure, O. G.; Fasmale, R. N.; Gandge, N. V.; Gholve, S. B.; Giram, P. S. QbD Approach for Analytical Method Development and Validation of Serotonin by Spectroscopic Method. Int. J. Pharm. Pharm. Sci. 2017, 10, 98–117.
  • Bhusnure, O. G.; Gandge, N. V.; Gholve, S. B.; Giram, P. S. QbD Approach for Analytical Method Development and Validation of Melatonin by Spectroscopic Method. J. Pharm. Res. 2017, 11, 464–471.
  • Sk. Mastanamma, P.; Saidulu, B.; Srilakshmi, N.; Ramadevi, D.; Prathyusha M. V.; Rani  . Analytical Quality by Design Approach for the Development of UV Spectrophotometric Method in the Estimation of Tenofovir Alafenamide in Bulk and Its Laboratory Synthetic Mixture. Res. J. Pharm. Technol. 2018, 11, 409–503. DOI: 10.5958/0974-360X.2018.00091.4.
  • Bhusnure, O. G.; Dongare, R. B.; Gholve, S. B. M.; Anoop, B.; Shette, R. S. QbD Approach for Analytical Method Development and Validation of Bisoprolol Fumarate by Spectroscopic Method. Int. J. Pharm. Biol. Sci. 2018, 8, 779–792.
  • Haque, M. A.; Bakshi, V.; Thippani, M.; Manda, R. M.; Boggula, N. Development and Validation of UV Spectrophotometric Method for the Determination of Dolutegravir by Using Quality by Design (QBD) Approach. JASR. 2021, 12, 113–119. DOI: 10.55218/JASR.s1202112313.
  • Thummar, K.; Pandya, M.; Patel, N.; Rawat, F.; Chauhan, S. Quality by Design-Based Development and Validation of UV-Spectrometric Method for the Determination of Remdesivir in Bulk and Marketed Formulation. Int. J. Pharm. Sci. Res. 2022, 14, 385–390. DOI: 10.25004/IJPSDR.2022.140404.
  • Jain, A.; Tikariya, K.; Mukherjee, J. Analytical Method Development Validation of Posaconazole by QbD Approach. Int. J Pharm. Sci. Rev. Res. 2022, 74, 109–113. DOI: 10.47583/ijpsrr.2022.v74i01.019.
  • Tanveer, A.; Wani, A.; Ahmad, S.; Zargar Nasr, Y.; Khalil, I. A.; Darwish  . Use of Response Surface Methodology for Development of New Microwell-Based Spectrophotometric Method for Determination of Atorvastatin Calcium in Tablets. Chem. Cent. J. 2012, 6, 1–9. DOI: 10.1186/1752-153X-6-134.
  • Singh, R.; Upadhyay, J.; Singh, D. DoE Assisted UV-Visible Spectrophotometric Method Development for Critical Factor Estimation Involved in Norfloxacin Degradation. Int. J. Pharm. Sci. Res. 2020, 11, 6289–6296. DOI: 10.13040/IJPSR.0975-8232.
  • Baghel, M.; Rajput, S. Development of Stability Indicating TLC Densitometry Method of Edaravone Using QbD Approach: Degradation Kinetic Study. IJPER. 2017, 51, s61–s68. DOI: 10.5530/ijper.51.2s.51.
  • Patil, A.; Shirkhedkar, A. Application of Quality by Design in the Development of HPTLC Method for Estimation of Anagliptin in Bulk and In-house Tablets. Eurasian J. Anal. Chem. 2017, 12, 443–458. DOI: 10.12973/ejac.2017.00181a.
  • Attala, K.; Eissa, M. S.; El-Henawee, M. M.; Abd El-Hay, S. S. Application of Quality by Design Approach for HPTLC Simultaneous Determination of Amlodipine and Celecoxib in Presence of Process-Related Impurity. Microchem. J. 2021, 162, 105857. DOI: 10.1016/j.microc.2020.105857.
  • Shah, P.; Pate, J.; Patel, K.; Gandhi, T. Development and Validation of an HPTLC Method for the Simultaneous Estimation of Clonazepam and Paroxetine Hydrochloride Using a DOE Approach. J. Taibah Univ. Sci. 2017, 11, 121–132. DOI: 10.1016/j.jtusci.2015.11.004.
  • Katakam, P.; Dey, B.; Hwisa, N. T.; Assaleh, F. H.; Chandu, B. R.; Singla, R. K.; Mitra, A. An Experimental Design Approach for Impurity Profiling of Valacyclovir-Related Products by RP-HPLC. Sci. Pharm. 2014, 82, 617–619. DOI: 10.3797/scipharm.1403-20.
  • Arpit, D.; Shah .; Patel C. N.. Implementation of QbD Approach to the RP-HPLC Method Development and Validation of Roflumilast in Bulk and Tablet Dosage Form: An Application in Degradation Study. World J. Pharm. Sci. 2014, 3, 2281–2307.
  • Chaphekar Purnima M. M..; Hamrapurkar D.. Development and Validation of RP-HPLC Assay Method for Vildagliptin Using QbD Approach and Its Application to Forced Degradation Studies. IJPSDR. 2016, 8, 157–165. DOI: 10.25004/IJPSDR.2016.080306.
  • Vijayaraj, S.; Palei, N. N.; Katyayani, T. Quality by Design (QbD) Approach to Develop HPLC Method for Estimation of Gliclazide and Its Impurity (Gliclazide Impurity A) in Bulk Drug. CPA. 2019, 15, 716–723. DOI: 10.2174/1573412914666180523092012.
  • Afzal, M.; Muddassir, M.; Alarifi, A.; Ansari, M. T. Box-Behnken Assisted Validation and Optimization of an RP-HPLC Method for Simultaneous Determination of Domperidone and Lansoprazole. Separations. 2021, 8, 5. DOI: 10.3390/separations8010005.
  • Chaudhari, S. R.; Shirkhedkar, A. A. Design of Experiment Avenue for Development and Validation of RP-HPLCPDA Method for Determination of Apremilast in Bulk and in In-House Tablet Formulation. J. Anal. Sci. Technol. 2019, 10, 1–9. DOI: 10.1186/s40543-019-0170-8.
  • Mittal, A.; Imam, S. S.; Parmar, S.; Sj, G.; Taleuzzaman, M. Design of Experiment Based Optimized RP-HPLC Method for Simultaneous Estimation of Amlodipine and Valsartan in Bulk and Tablet Formulations. Austin J. Anal. Pharm. Chem. 2015, 2, 1–6.
  • Pangeni, R.; Ali, J.; Mustafa, G.; Sharma, S.; Baboota, S. Design Expert-Supported Development and Validation of Stability Indicating High-Performance Liquid Chromatography Method for Determination of Resveratrol in Bulk Drug and Pharmaceutical Formulation. Int. J. Pharm. Sci. Res. 2015, 6, 5115–5125. DOI: 10.13040/IJPSR.0975-8232.6(12).5115-25.
  • Panda, S. S.; Ravi Kumar, V. V. B.; Beg, S.; Sahu, S. K.; Muni, S. Development and Validation of a Stability- Indicating Liquid Chromatographic Method for Estimating Vilazodone Hydrochloride in Pharmaceutical Dosage Form Using Quality by Design. J. Chromatogr. Sci. 2016, 54, 1713–1722. DOI: 10.1093/chromsci/bmw127.
  • Garg, N. K.; Sharma, G.; Singh, B.; Nirbhavane, P.; Katare, O. P. Quality by Design (QbD) Based Development and Optimization of a Simple, Robust RP-HPLC Method for the Estimation of Methotrexate. J. Liq. Chromatogr. Relat. 2015, 38, 1629–1637. DOI: 10.1080/10826076.2015.1087409.
  • Vitthal Babar, A.; Jain, G.; Patel, J.; Sharma, R.; Khan, S.; Patel, R. QbD Approach in HPLC Method Development and Validation of Tamoxifen. IJPSM. 2022, 7, 90–105. DOI: 10.47760/ijpsm.2022.v07i09.006.
  • Singh Sandhu, P.; Beg, S.; Kumar, R.; Katare, O. P.; Singh, B. Analytical QbD Based Systematic Bioanalytical HPLC Method Development for Estimation of Quercetin Dihydrate. J. Liq. Chromatogr. Relat. 2017, 40, 506–516. DOI: 10.1080/10826076.2017.1329744.
  • Wang, L.; Qu, H. Development and Optimization of SPE-HPLC-UV/ELSD for Simultaneous Determination of Nine Bioactive Components in Shenqi Fuzheng Injection Based on Quality by Design Principles. Anal. Bioanal. Chem. 2016, 408, 2133–2145. DOI: 10.1007/s00216-016-9316-3.
  • Singh Sandhu, P.; Beg, S.; Katare, O. P.; Singh, B. QbD-Driven Development and Validation of a HPLC Method for Estimation of Tamoxifen Citrate with Improved Performance. J. Chromatogr. Sci. 2016, 54, 1373–1384. DOI: 10.1093/chromsci/bmw090.
  • Sahu, P. K.; Patro, C. S. Application of Chemometric Response Surface Methodology in Development and Optimization of a RP-HPLC Method for the Separation of Metaxalone and Its Base Hydrolytic Impurities. J. Liq. Chromatogr. Relat. 2014, 37, 2444–2464. DOI: 10.1080/10826076.2013.840841.
  • Bhaskaran, N. A. J.; Kumar, L.; Sreenivasa Reddy, M.; Girish Pai, K. An Analytical “Quality by Design” Approach in RP-HPLC Method Development and Validation for Reliable and Rapid Estimation of Irinotecan in an Injectable Formulation. Acta Pharm. 2021, 71, 57–79. DOI: 10.2478/acph-2021-0008.
  • Sachin, B.; Gholve, J. N.; Sangshetti Omprakash, G.; Bhusnure, R. S.; Sakhare, Pratap, H.; Bhosale M. I.; Mouzam . RP-HPLC Method Development and Validation for the Estimation of Lansoprazole in Presence of Related Substances by QbD Approach. J. Pharm. Res. Int. 2021, 33, 138–150.
  • Yahya, B. A.; Bawazir, A. S.; Sangshetti, J. N.; Baig, S. S.; Shaikh, S. S. QbD Based Development and Validation of an Efficient RP-HPLC Method for Estimation of Abiraterone Acetate in Bulk, Tablet, and In-House-Developed Nano-Formulation. Anal. Chem. Lett. 2021, 11, 112–130. DOI: 10.1080/22297928.2021.1888794.
  • El-Bagory, I.; Alruwaili, N. K.; Imam, S. S.; Alomar, F. A.; Elkomy, M. H.; Ahmad, N.; Elmowafy, M.; Ameeduzzafar . Quality by Design (QbD) Based Development and Validation of Bioanalytical RP-HPLC Method for Dapagliflozin: Forced Degradation and Preclinical Pharmacokinetic Study. J. Liq. Chromatogr. Relat. 2020, 43, 53–65. DOI: 10.1080/10826076.2019.1667820.
  • Kankariya, T. S.; Shaikh, S. M.; Anantwar, P.; Shelke, V. M.;. Ingle, Y. S.; Sayyad, D. M. Application of Quality by Design Approach for Development and Validation of Analytical RP-HPLC Method for Prasugrel HCl in Bulk and Tablet Dosage Form. Int. J. Sci. Res. 2019, 8, 1271–1280. DOI: 10.21275/ART20203439.
  • Patil, T. S.; Deshpande, A. S. Development of an Innovative Quality by Design (QbD) Based Stability-Indicating HPLC Method and Its Validation for Clofazimine from Its Bulk and Pharmaceutical Dosage Forms. Chromatographia. 2019, 82, 579–590. DOI: 10.1007/s10337-018-3660-8.
  • Ganorkar, S. B.; Dhumal, D. M.; Shirkhedkar, A. A. Development and Validation of Simple RP-HPLC-PDA Analytical Protocol for Zileuton Assisted with Design of Experiments for Robustness Determination. Arab. J. Chem. 2014, 10, 273–282. DOI: 10.1016/j.arabjc.2014.03.009.
  • Sudha, T.; Shanmugasundram, P. Simultaneous Optimization of the Resolution and Analysis Time in RP-HPLC Method for Abacavir and Lamivudine Using Derringer’s Desirability Function. Int. J. Pharmtech. Res. 2014, 6, 1040–1048.
  • Sudha, T.; Shanmugasundram, P. RP-HPLC Method for Simultaneous Determination of Emtricitabine, Rilpivirine and Tenofovir Employing Response Surface Design. Int. J. Pharm. 2014, 4, 256–264.
  • Beg, S.; Sharma, G.; Katare, O. P.; Lohan, S.; Singh, B. Development and Validation of a Stability Indicating Liquid Chromatographic Method for Estimating Olmesartan Medoxomil Using Quality by Design. J Chromatogr. Sci. 2015, 53, 1–12. DOI: 10.1093/chromsci/bmu165.
  • Ashok Kumar, P.; Thirupathi, D.; Ravindra Kumar, Y.; Jayashree, A. Simultaneous Determination of Related Organic Impurities of Ibuprofen and Paracetamol in Combination Solid Dosage Form by RP-HPLC with QbD Approach. Orient. J. Chem. 2017, 33, 1461–1468. DOI: 10.13005/ojc/330349.
  • Dawud, E. R.; Shakya, A. K. HPLC-PDA Analysis of ACE-Inhibitors, Hydrochlorothiazide and Indapamide Utilizing Design of Experiments. Arab. J. Chem. 2019, 12, 718–728. DOI: 10.1016/j.arabjc.2014.10.052.
  • Manikandan, K.; Lakshmi, K. S.; Pai, A. QbD Approach in RP-HPLC Method Development for the Assay of Benzocaine and Diclofenac in Dosage Forms. AIP Conf Proc. 2019, 2112, 020083. DOI: 10.1063/1.5112268.
  • Dongala, T.; Katakam, L. N. R.; Palakurthi, A. K.; Katari, N. K. RP-HPLC Stability Indicating Method Development and Validation of Pseudoephedrine Sulfate and Related Organic Impurities in Tablet Dosage Forms, Robustness by QbD Approach. Anal. Chem. Lett. 2019, 9, 697–710. DOI: 10.1080/22297928.2019.1696701.
  • Gundala, A.; Prasad, K.; Koganti, B. Application of Quality by Design Approach in RP-HPLC Method Development for Simultaneous Estimation of Saxagliptin and Dapagliflozin in Tablet Dosage Form. Braz. J. Pharm. Sci. 2019, 55, 1–10. DOI: 10.1590/s2175-97902019000218129.
  • Prajapati, R.; Dedania, Z.; Jain, V.; Sutariya, V.; Dedania, R.; Chisti, Z. QbD Approach to HPLC Method Development and Validation for Estimation of Fluoxetine Hydrochloride and Olanzapine in Pharmaceutical Dosage Form. J. Emerg. Technol. Innov. Res 2019, 6, 179–195.
  • Veerubhotla, K.; Walker, R. B. Development and Validation of a Stability-Indicating RP-HPLC Method Using Quality by Design for Estimating Captopril. Pharm. Sci. 2019, 81, 45–56. DOI: 10.4172/pharmaceutical-sciences.1000478.
  • Vijayaraj, S.; Palei, N. N.; Archana, D.; Lathasri, K.; Rajavel, P. Quality by Design (QbD) Approach to Develop Stability Indicating HPLC Method for Estimation of Rutin in Chitosan-Sodium Alginate Nanoparticles. Braz. J. Pharm. Sci. 2020, 56, e18793. DOI: 10.1590/s2175-97902020000318793.
  • Krishnan, B.; Mishra, K. Quality by Design-Based Development and Validation of RP-HPLC Method for Simultaneous Estimation of Sitagliptin and Metformin in Bulk and Pharmaceutical Dosage Forms. IJPI. 2020, 10, 512–518. DOI: 10.5530/ijpi.2020.4.89.
  • Gad, M. A.; Amer, S. M.; Zaaza, H. E.; Hassan, S. A. Strategies for Stabilizing Formulation and QbD Assisted Development of Robust Stability Indicating Method of Azilsartan Medoxomil/Chlorthalidone. J. Pharm. Biomed. Anal. 2020, 178, 112910. DOI: 10.1016/j.jpba.2019.112910.
  • Annapurna, M. M.; Venkatesh, B.; Chaithanya, K. R. Quality by Design Approach (QbD) for the Simultaneous Determination of anti-Hypertensive Drugs (Candesartan, Irbesartan and Hydrochlorothiazide) by RP-HPLC. J. Anal. Pharm. Res. 2017, 4, 1–17. DOI: 10.15406/japlr.2017.04.00118.
  • Fouad, M. A.; Elsabour, S. A.; Elkady, E. F.; Elshazly, H. M. Design of Experiment (DOE), Multiple Response Optimization and Utilizing the Desirability Function in the Simultaneous HPLC Separation of Five Antihypertensive Drugs. J. Iran. Chem. Soc. 2022, 19, 269–282. DOI: 10.1007/s13738-021-02316-7.
  • Babar, S. A.; L. Padwal, S. QbD Approach to Analytical Method Development and Its Validation for Estimation of Lenvatinib in Bulk and Pharmaceutical Formulation. Int. J. App. Pharm. 2021, 13, 183–188. DOI: 10.22159/ijap.2021v13i5.41786.
  • Sha’at, M.; Spac, A. F.; Stoleriu, I.; Bujor, A.; Cretan, M. S.; Hartan, M.; Ochiuz, L. Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Metformin Hydrochloride in Tablet Dosage Forms by HPLC. Pharmaceutics. 2022, 14, 1187. DOI: 10.3390/pharmaceutics14061187.
  • Kaur, R.; Saini, S.; Patel, A.; Sharma, T.; Kaur, R.; Katare, O. P.; Singh, B. Developing a Validated HPLC Method for Quantification of Ceftazidime Employing Analytical Quality by Design and Monte Carlo Simulations. J. AOAC Int. 2021, 104, 620–632. DOI: 10.1093/jaoacint/qsab014.
  • Sebaiy, M. M.; El-Ad, S. M.; Baraka, M. M.; Hassan, A. A.; Heba El-Sayed, H. M. Quality by Design Approach for Development and Validation of a RP‑HPLC Method for Simultaneous Estimation of Xipamide and Valsartan in Human Plasma. BMC Chem. 2022, 70, 1–13. DOI: 10.1186/s13065-022-00864-4.
  • Jain, A.; Beg, S.; Saini, S.; Sharma, T.; Katare, O. P.; Singh, B. Application of Chemometric Approach for QbD Enabled Development and Validation of an RP-HPLC Method for Estimation of Methotrexate. J. Liq. Chromatogr. Relat. 2019, 42, 502–512. DOI: 10.1080/10826076.2019.1626742.
  • Sharma, G.; Thakur, K.; Raza, K.; Katare, O. P. Stability Kinetics of Fusidic Acid: development and Validation of Stability Indicating Analytical Method by Employing Analytical Quality by Design Approach in Medicinal Product(s). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2019, 1120, 113–124. DOI: 10.1016/j.jchromb.2019.05.001.
  • Saini, S.; Sharma, T.; Patel, A.; Kaur, R.; Tripathi, S. K.; Katare, O. P.; Singh, B. QbD-Steered Development and Validation of RP-HPLC Method for Quantification of Ferulic Acid: Rational Application of Chemometric Tools. J. Chromatogr. B. 2020, 1155, 122300. DOI: 10.1016/j.jchromb.2020.122300.
  • Perumal, D. D.; Krishnan, M.; Lakshmi, K. S. Eco-Friendly Based Stability-Indicating RP-HPLC Technique for the Determination of Escitalopram and Etizolam by Employing QbD Approach. Green Chem. Lett. Rev. 2022, 15, 671–682. DOI: 10.1080/17518253.2022.2127334.
  • Ashok, K; Shakya . Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Determination of Valsartan and Hydrochlorthiazide Using Quality by Design. Orient. J. Chem. 2016, 32, 777–788. DOI: 10.13005/ojc/320203.
  • Somana Siva Prasad, B.; Babu Kasimala, V.; Rao, A. QbD Based Analytical Method Development and Validation for the Separation and Quantification of Agomelatine and Its Impurities in Solid Oral Dosage Forms Using HPLC. Rasayan J. Chem. 2021, 14, 2183–2190. DOI: 10.31788/RJC.2021.1446426.
  • Modi, P. K. B.; Shah, N. J. DoE Approach: A Stability Indicating RP-HPLC Method for Simultaneous Estimation of Methylparaben, Mometasone Furoate and Eberconazole Nitrate in Topical Formulations. J. Appl. Pharm. Sci. 2014, 4, 020–025. DOI: 10.7324/JAPS.2014.41204.
  • Shah, U.; Shah, K.; Patel, R. Stability-Indicating Analytical Method Development Using Quality by Design Approach for Simultaneous Estimation of Ezetimibe and Glimepiride. Pharm. Sci. 2019, 81, 81. DOI: 10.36468/pharmaceutical-sciences.508.
  • Omprakash, G.; Bhusnure, N. G.; Shinde Sachin, B.; Gholve P. S.; Giram . QbD Approach for Analytical Method Development of Anti-Pschotic Drug. Der Pharm. Lett. 2015, 7, 62–70.
  • Vignaduzzo, S. E.; Castellano, P. M.; Kaufman, T. S. Experimentally Designed, Validated HPLC Simultaneous Determination of Pridinol and Diclofenac in Their Combined Pharmaceutical Formulations, Which Allows Limiting Diclofenac Related Compound A. J. Liq. Chromatogr. Relat. 2010, 33, 1720–1732. DOI: 10.1080/10826076.2010.519239.
  • Gurumukhi, V. C.; Bari, S. K. B. Quantification and Validation of Stability-Indicating RP-HPLC Method for Efavirenz in Bulk and Tablet Dosage Form Using Quality by Design (QbD): a Shifting Paradigm. J. Chromatogr. Sci. 2022, 60, 143–156. DOI: 10.1093/chromsci/bmab061.
  • Shilpa, R.; Mandpe Vishal, R.; Parate J. B.; Naik . Experimental Design Approach, Screening and Optimization of System Variables, Analytical Method Development of Flurbiprofen in Nanoparticles and Stability‑Indicating Methods for High‑Pressure Liquid Chromatography. Future J. Pharm. Sci. 2022, 8, 1–21. DOI: 10.1186/s43094-022-00426-4.
  • Golembiovska, О.; Voskoboinik, O.; Berest, G.; Kovalenko, S.; Logoyda, L. Quality by Design Approach for Simultaneous Determination of Original Active Pharmaceutical Ingredient Quinabut and Its Impurities by Using HPLC. PHAR. 2021, 68, 79–87. DOI: 10.3897/pharmacia.68.e50704.
  • Vamsi Krishna, M.; Dash, R. N.; Jalachandra Reddy, B.; Venugopal, P.; Sandeep, P.; Madhavi, G. Quality by Design (QbD) Approach to Develop HPLC Method for Eberconazole Nitrate: Application to Hydrolytic, Thermal, Oxidative and Photolytic Degradation Kinetics. J. Saudi Chem. Soc. 2013, S313-S322. DOI: 10.1016/j.jscs.2012.12.001.
  • Santosh, S.; Bhujba, S. L.; Darkunde. Analytical Method Development and Optimization of Sofosbuvir Drug – AQbD Approach. Int. J. Pharm. Sci. Res. 2019, 10, 108–116. DOI: 10.13040/IJPSR.0975-8232.10(1).108-16.
  • Jaybhave, A. R.; Shinde, M.; Mogal, R.; Narkhede, S.; Jadhav, A. QbD Approach to Analytical RP-HPLC Method Development and Validation of Tenofovir Disoproxil Fumarate in Dosage Form. J. Pharm. Sci. Res. 2021, 13, 381–386.
  • Bossunia, M. T. I.; Farjana Urmi, K.; Kumar Shaha, C. Quality by Design Approach to Stability Indicating RP-HPLC Analytical Method Development for Estimation of Canagliflozin API and Its Validation. PHME. 2017, 8, 92–101.
  • Devesh, A.; Bhatt S. I.; Rane . QbD Approach to Analytical RP-HPLC Method Development and Its Validation. Int. J. Pharm. Pharm. Sci. 2011, l3, 179–187.
  • Sultana, S.; Kumar, U.; Shahadat Hossain, M.; Lira, D. N. L.; Abu, S. S. R. QbD Approach for the Development and Validation of RP-UHPLC Method for Quantitation of Vildagliptin. J. Pharm. Sci. 2017, 16, 107–117.
  • Vishnuvardhan, C.; Srinivas, R.; Satheeshkumar, N. Development and Validation of a UPLC Method for Screening Potentially Counterfeit anti-Hypertensive Drugs Using Design of Experiment. Anal. Methods. 2014, 6, 4610–4616. DOI: 10.1039/C4AY00384E.
  • Nadella, N. P.; Ratnakaram, V. N.; Srinivasu, N. Quality by Design-Based Development and Validation of a Stability-Indicating UPLC Method for Quantification of Teriflunomide in the Presence of Degradation Products and Its Application to Invitro Dissolution. J. Liq. Chromatogr. Relat. 2017, 40, 517–527. DOI: 10.1080/10826076.2017.1330211.
  • Nadella, N. P.; Ratnakaram, V. N.; Srinivasu, N. Development and Validation of UPLC Method for Simultaneous Quantification of Carvedilol and Ivabradine in the Presence of Degradation Products Using DoE Concept. J. Liq. Chromatogr. Relat. 2018, 41, 143–153. DOI: 10.1080/10826076.2018.1427595.
  • Panda, S. S.; Sharma, K.; Mohanty, B.; Kumar, R.; Varaha Bera, V.; Acharya, S. K.; Beg, S. Integrated Quality by Design (QbD) and Design of Experiments (DoE) Approach for UFLC Determination of Telaprevir in Rat Serum. J. Liq. Chromatogr. Relat. 2017, 40, 951–958. DOI: 10.1080/10826076.2017.1387558.
  • Panda, S. S.; Sharma, K.; Mohanty, B.; Bera, R. K. V. V.; Kumari Acharjya, S.; Chowdhury, B. Quality by Design (QbD) Enabled Enhanced Bioanalytical Extraction and UFLC Determination of Vilazodone from Rat Serum. J. Liq. Chromatogr. Relat. 2017, 40, 775–782. DOI: 10.1080/10826076.2017.1360908.
  • Hasnain, M. S.; Ansari, S. A.; Rao, S.; Tabish, M.; Singh, M.; Abdullah, M. S.; Ansari, M. T. QbD Driven Development and Validation of Liquid Chromatography Tandem Mass Spectrometric Method for the Quantitation of Sildenafil in Human Plasma. J. Chromatogr. Sci. 2017, 55, 587–594. DOI: 10.1093/chromsci/bmx010.
  • Saha, C.; Vishal Gupta, N.; Chandan, R. S. Development and Validation of a UPLC-MS Method for Determination of Atazanavir Sulfate by the Analytical Quality by Design Approach. Acta Pharm. 2020, 70, 17–33. DOI: 10.2478/acph-2020-0008.
  • Sankar, A. S. K.; Sundaram Palani, S.; Velayudham, R. C. Quality by Design Applied Liquid Chromatography- Tandem Mass Spectrometry Determination of Enzalutamide Anti-Prostate Cancer Therapy Drug in Spiked Plasma Samples. Anal. Chem. Insights. 2017, 12, 117739011772677. DOI: 10.1177/1177390117726776.
  • Jayagopal, B.; Murugesh, S. QbD Driven HPLC Method of Eltrombopag Olamine: Degradation Pathway Proposal, Structure Elucidation, and In Silico Toxicity Prediction. J. Pharm. Biomed. Anal. 2021, 203, 114231. DOI: 10.1016/j.jpba.2021.114231.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.